Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Colgate Total PROTECTION ACTIVE** is a branded fluoridated dentifrice used as the active-comparator intervention in the Dubai Health-sponsored Phase 2 MIH-CARE study in children aged 6–12 years with mild to moderate molar incisor hypomineralization. The registered study identifies it as a fluoridated toothpaste but does not provide a complete product composition, fluoride salt, concentration, or SKU. Products in the Colgate Total Active Prevention family are marketed by Colgate-Palmolive as stannous-fluoride toothpastes; fluoride promotes enamel remineralization and reduces acid-mediated demineralization, while stannous fluoride may also reduce plaque-associated bacterial activity. This is a topical oral-care drug product rather than a systemic therapeutic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colgate Total PROTECTION ACTIVE.